LXEO Operating Cash Flow (Statement)
Lexeo Therapeutics Inc · Operating Cash Flow (Statement)
LXEO Operating Cash Flow (Statement)
Latest reported-$17.60Mperiod ending
LXEO Quarterly Cash from Operations (-$15.09M → -$17.60M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
LXEO operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -17,597,000 | |
| -21,144,000 | |
| -20,079,000 | |
| -29,547,000 | |
| -27,219,000 | |
| -21,716,000 | |
| -28,326,000 | |
| -17,806,000 | |
| -20,152,000 | |
| -14,867,000 | |
| -13,981,000 | |
| -13,949,000 | |
| -13,190,731 | |
| -18,374,000 | |
| -16,626,000 | |
| -11,789,000 | |
| -11,050,205 | |
| -15,094,795 |